Quinapril Hydrochloride
4 NDCs across 1 manufacturer|4 Generic,0 Brand
Quinapril Hydrochloride is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 19, 1991, and the first generic was approved Dec 15, 2004. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient.
Quinapril Hydrochloride is available as 4 NDCs from 1 manufacturer (4 generic, 0 brand), with NADAC prices from $0.08 to $0.10 per EA — a 28% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
16 Quinapril Hydrochloride presentations are currently listed in FDA's drug shortage database (first posted Jan 19, 2023). Shortages can move NADAC prices in the following weeks.
Total NDCs
4
4G / 0B
Manufacturers
1
competing in market
Price Spread
$0.08 – $0.10
per EA
7d Activity
avg +0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin Converting Enzyme Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing QUINAPRIL HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
QUINAPRIL 10 MG TABLET | $0.0968 per EA | — |
QUINAPRIL 20 MG TABLET | $0.0964 per EA | — |
QUINAPRIL 40 MG TABLET | $0.0960 per EA | — |
QUINAPRIL 5 MG TABLET | $0.0753 per EA | — |
Frequently Asked Questions
What is Quinapril Hydrochloride used to treat?
Quinapril Hydrochloride is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
When did Quinapril Hydrochloride become available as a generic?
FDA approved the first generic Quinapril Hydrochloride (ANDA) on Dec 15, 2004. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
Is Quinapril Hydrochloride in shortage?
Yes — FDA's drug shortage database currently lists 16 Quinapril Hydrochloride presentations with status "Current", first posted Jan 19, 2023.
How many Quinapril Hydrochloride products are on the market?
The Quinapril Hydrochloride drug market contains 4 NDCs from 1 manufacturer — 4 generic and 0 brand products.
What is the price range for Quinapril Hydrochloride?
NADAC reference prices for Quinapril Hydrochloride range from $0.0753 to $0.0968 per EA — a 28% difference between cheapest and most expensive.
Which manufacturers make Quinapril Hydrochloride?
1 manufacturer lists Quinapril Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (4).